The impact of patient information leaflets to prevent hypoglycemia in out patients with type 2 diabetes mellitus

Pediatric patients with Type 2 Diabetes Mellitus will have a worse fatty acid profile associated with inflammation compared with patients with Metabolic Syndrome

(1) original quantitative studies conducted during the COVID-19 outbreak, (2) patients with chronic disease (diabetes type 1 and type 2, hypertension, hyperlipi- demia, dyslipidemia,

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy (CREDENCE), Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients with Chronic Kidney

Type 2 diabetes, type 2 diabetes adjusted for BMI, fasting glucose, fasting glucose adjusted for BMI, fasting insulin, fasting insulin adjusted for BMI, diastolic blood

Using monocyte-derived macrophages (MDMs) obtained from peripheral blood mononuclear cells (PBMCs) from a previously characterized cross-sample of pediatric T2DM patients

Experimental stud- ies have described that with non-surgical periodon- tal therapy, in diabetic patients there is a significant reduction in total volume of GCF (gingival crevic-

The higher hsCRP levels observed in children with type 1 diabetes compared with a control group with a similar BMI and lower than children with severe obesity suggest a

Only a small number of pediatric patients with positive testing for COVID-19 were reported in this global survey: 61 with type 1 diabetes mellitus and 25 with type 2... Their